Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2024年6月18日 - 5:01AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
6-K
Report
of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For
the month of June 2024
Commission File No.: 001-35165
BRAINSWAY
LTD.
(Translation of registrant's name into English)
19
Hartum Street
Bynet Building, 3rd Floor
Har HaHotzvim
Jerusalem, 9777518, Israel
(+972-2)
582-4030
(Address of principal executive office)
Indicate by check mark
whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ] Form
40-F [ ]
CONTENTS
Results of Annual
Shareholder Meeting
At
the Annual General Meeting of Shareholders of BrainsWay Ltd. (the “Company”) held on June 17, 2024, a quorum of votes
being duly represented, all proposed resolutions were approved by the respective required majority of the shareholders. Below are
the proposals which were adopted, as well as the respective share of support each resolution received:
(1)
To appoint Kost Forer Gabbay & Kasierer, certified public accountants in Israel and a member of Ernst & Young Global, as the Company’s
independent auditors for the year as described in the Proxy Statement and for an additional period until the next annual general meeting
and to authorize the Board of Directors to determine their compensation for the year; and to inform the shareholders of the aggregate
compensation paid to the auditors for the year ended December 31, 2023.
Votes
in Favor |
|
Votes
Against |
|
Abstentions |
14,983,707 |
|
11,004 |
|
652 |
(2)
To approve the election or re-election of the following:
(a)
Mr. Ami Boehm as a director on the Board of Directors of the Company until the next annual general meeting.
Votes
in Favor |
|
Votes
Against |
|
Abstentions |
14,972,035 |
|
22,628 |
|
700 |
(b)
Dr. David Zacut as a director on the Board of Directors of the Company until the next annual general meeting.
Votes
in Favor |
|
Votes
Against |
|
Abstentions |
14,969,035 |
|
25,628 |
|
700 |
(c)
Mr. Avner Hagai as a director on the Board of Directors of the Company until the next annual general meeting.
Votes
in Favor |
|
Votes
Against |
|
Abstentions |
14,816,095 |
|
178,568 |
|
700 |
(d)
Ms. Eti Mitrany as a director on the Board of Directors of the Company until the next annual general meeting.
Votes
in Favor |
|
Votes
Against |
|
Abstentions |
14,969,425 |
|
24,238 |
|
1,700 |
(e)
Ms. Karen Sarid as a director on the Board of Directors of the Company until the next annual general meeting.
Votes in Favor |
|
Votes
Against |
|
Abstentions |
14,966,425 |
|
28,238 |
|
700 |
(f)
Prof. Avraham Zangen as a director on the Board of Directors of the Company until the next annual general meeting.
Votes
in Favor |
|
Votes
Against |
|
Abstentions |
14,969,343 |
|
25,320 |
|
700 |
(g)
Mr. Yossi Ben Shalom as a director on the Board of Directors of the Company until the next annual general meeting.
Votes
in Favor |
|
Votes
Against |
|
Abstentions |
14,833,975 |
|
160,688 |
|
700 |
(h)
Mr. Avner Lushi as a director on the Board of Directors of the Company until the next annual general meeting.
Votes
in Favor |
|
Votes
Against |
|
Abstentions |
14,836,379 |
|
158,284 |
|
700 |
(3)
To approve compensation and a grant of equity in the form of options and restricted share units for Ami Boehm for his role as the chairman
of the Board of Directors.
Votes
in Favor |
|
Votes
Against |
|
Abstentions |
11,772,164 |
|
3,217,499 |
|
5,700 |
(4)
To approve the grant of equity in the form of options and restricted share units to the directors of the Company.
Votes
in Favor |
|
Votes
Against |
|
Abstentions |
13,182,588 |
|
1,808,075 |
|
4,700 |
(5)
to approve the grant of equity in the form of options and restricted share units to Mr. Hadar Levy, the Company’s Chief Executive
Officer.
Votes
in Favor (excluding shareholders indicating personal interest) |
|
Votes
Against |
|
Abstentions |
7,645,476 |
|
3,214,075 |
|
4,740 |
(6)
to approve the Compensation Policy of the Company as set forth in the Proxy Statement.
Votes
in Favor (excluding shareholders indicating personal interest) |
|
Votes
Against |
|
Abstentions |
5,980,371 |
|
1,794,325 |
|
3,270 |
Incorporation
by Reference
The
contents of this Form 6-K are incorporated by reference in the Company’s registration statement on Form F-3, on September
17, 2021 (Registration No. 333-259610), and Form S-8, SEC Registration No. 333-230979, filed by the Company with the SEC on April
22, 2019, and shall be a part thereof from the date on which this Form 6-K is furnished, to the extent not superseded by documents
or reports subsequently filed or furnished.
Signatures
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
BRAINSWAY LTD. |
|
|
|
|
Date: June 17, 2024 |
By: /s/ Ami Boehm |
|
Ami Boehm, Chairman of the Board of Directors |
Brainsway (PK) (USOTC:BRSYF)
過去 株価チャート
から 5 2024 まで 6 2024
Brainsway (PK) (USOTC:BRSYF)
過去 株価チャート
から 6 2023 まで 6 2024